ETHICA

Live / Registered — Registered and renewed (as of 23 Feb 2017)

What this means for you

Registered since 26 Dec 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Dec 2016).

Record

Serial number
78277322
Registration number
3188634
Mark type
Word mark
Filed
22 Jul 2003
Published for opposition
10 Oct 2006
Registered
26 Dec 2006
Next maintenance due
26 Dec 2016
Attorney of record
Dan S. Cohn

Goods and services

  • Class 035 — Advertising and business services: Clinical trial supplies management services, namely-customized drug packaging and labeling, central and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical supplies, namely study drugs and devices, case report forms, study binders and all study related documentation; clinical trial management services, namely-pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, close-out visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; managing the development of all study related documents and materials, namely study protocols, amendments, paper and electronic case report forms, and informed consent forms; managing study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters; management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; managing all aspects of study drug reconciliation and inventory and distribution reports; managing all aspects of clinical trials, namely managing investigators, technicians, and participants, ethical reviews, investigator meetings, databases, statistical analyses and reporting, randomization logistics, medical writing services; recruitment of investigators, technicians and participants; providing strategies for recruitment of participants
  • Class 041 — Education and entertainment services: Study specific clinical personnel training programs for investigators, coordinators and investigator meetings; conducting investigator meetings
  • Class 042 — Scientific and technological services: Research services for clinical trials for others, namely conducting an ethical review of projects to protect the rights and welfare of research participants, developing study protocols, designing case report forms, developing participant screening tools, namely general and medical questionnaires, developing complete databases in accordance with strict guidelines, tracking of study parameters, providing statistical analyses, reporting and developing tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; developing and implementing randomization logistics, namely randomization envelopes, customized blind-breakable drug labeling, code break management and reports, manufacturing of subject-and protocol-specific kits using bulk oral and topical medications; medical writing services, namely-drafting clinical study protocols, amendments, case report forms, informed consent forms, statistical analysis plans, full integrated clinical research reports, publications, abstracts and manuscript; developing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; developing study operations and monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters

Owner

Prosecution history

  • 26 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 20 Sept 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 23 Feb 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 23 Feb 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 23 Feb 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 23 Feb 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 22 Dec 2016 — TEAS SECTION 8 & 9 RECEIVED
  • 26 Dec 2015 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 16 Jan 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 15 Jan 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 15 Jan 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 20 Dec 2012 — TEAS SECTION 8 & 15 RECEIVED
  • 23 Nov 2009 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 23 Nov 2009 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 29 Jan 2007 — EXPARTE APPEAL TERMINATED

View this trademark record on Marksy